Infantile Stage M Neuroblastoma With 11q Deletion, Mimicking Stage MS
暂无分享,去创建一个
[1] A. M. Caroleo,et al. A Review of Infants With Localized Neuroblastoma That Evolve to Stage 4s Disease. , 2020, Journal of pediatric hematology/oncology.
[2] A. Naranjo,et al. Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Verri,et al. Genome instability model of metastatic neuroblastoma tumorigenesis by a dictionary learning algorithm , 2015, BMC Medical Genomics.
[4] O. Delattre,et al. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study) , 2011, British Journal of Cancer.
[5] Gudrun Schleiermacher,et al. Accumulation of segmental alterations determines progression in neuroblastoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Ruth Ladenstein,et al. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Ruth Ladenstein,et al. Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Barbara Hero,et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Giovanni Cecchetto,et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Audrey Kauffmann,et al. MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S , 2008, Molecular oncology.
[11] S. Yoo,et al. Pancreatic Metastasis in a Child Suffering with Treated Stage 4 Neuroblastoma , 2008, Korean journal of radiology.
[12] F. Berthold,et al. Loss in Chromosome 11q Identifies Tumors with Increased Risk for Metastatic Relapses in Localized and 4S Neuroblastoma , 2006, Clinical Cancer Research.
[13] P. Babyn,et al. Neuroblastoma with atypical metastases to cardiac and skeletal muscles: MRI features , 2003, Pediatric Radiology.
[14] F. Berthold,et al. Metastatic neuroblastoma in infancy: what does the pattern of metastases contribute to prognosis? , 2000, Medical and pediatric oncology.